Will differentiation of Daewoong Pharmaceutical be magnified in the Baraclude market?
Daewoong Pharmaceutical will challenge to the type B liver cancer treatment.
According to the industry concerned, Daewoong Pharmaceutical and CTC Bio have been approved for generic products of Baraclude(BMS).
The products of the two companies are unique among their competing products as they ar...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
